Frank Savage - Rite Aid Independent Director
RADDelisted Stock | USD 0.17 0.01 5.56% |
Director
Mr. Frank A. Savage is no longer Independent Director of the Company effective Oct. 30, 2018. He was a senior advisor to investment banking firm Lazard Ltd. since January 1, 2014 and served as Vice Chairman of U.S. Investment Banking at Lazard from 2009 to December 31, 2013. He was the CoHead of Lazard Restructuring Group from June 1999 to December 31, 2013 and also served on Lazard Deputy Chairman Committee from 2006 to December 2013. Prior to joining Lazard, Mr. Savage served as CoHead of the Restructuring Practice at investment banking firm BT Alex. Brown Inc. and before that was the Head of the Restructuring Group at investment bank UBS AG. Mr. Savage is currently a director and member of the Corporationrationrate Governance and Nominating Committee of SUPERVALU INC.
Age | 68 |
Phone | 717 761 2633 |
Web | https://www.riteaid.com |
Rite Aid Management Efficiency
Rite Aid's management efficiency ratios could be used to measure how well Rite Aid manages its routine affairs as well as how well it operates its assets and liabilities.The company has 5.82 B in debt. Rite Aid has a current ratio of 1.3, demonstrating that it may have difficulties to pay its financial commitments when the payables are due. Debt can assist Rite Aid until it has trouble settling it off, either with new capital or with free cash flow. So, Rite Aid's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Rite Aid sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Rite to invest in growth at high rates of return. When we think about Rite Aid's use of debt, we should always consider it together with cash and equity.
Similar Executives
Showing other executives | DIRECTOR Age | ||
Ju Li | Bimi International Medical | 39 | |
Christopher Mills | SunLink Health Systems | 67 | |
Caroline Wang | China Jo Jo Drugstores | 30 | |
Howard Turner | SunLink Health Systems | 76 | |
Fengsheng Tan | Bimi International Medical | N/A | |
Taihong Guo | China Jo Jo Drugstores | 66 | |
Nancy Schlichting | Walgreens Boots Alliance | 63 | |
Gene Burleson | SunLink Health Systems | 77 | |
Janice Babiak | Walgreens Boots Alliance | 60 | |
Pingfan Wu | China Jo Jo Drugstores | 52 | |
Leonard Schaeffer | Walgreens Boots Alliance | 72 | |
Ginger Graham | Walgreens Boots Alliance | 62 | |
Steven Baileys | SunLink Health Systems | 64 | |
Karen Brenner | SunLink Health Systems | 63 | |
Frank Formica | PetMed Express | 73 | |
Mia Ching | Bimi International Medical | 49 | |
Jiangliang He | China Jo Jo Drugstores | 55 | |
Gian Fulgoni | PetMed Express | 69 | |
Ronald Korn | PetMed Express | 77 | |
John Lederer | Walgreens Boots Alliance | 62 | |
Barry Rosenstein | Walgreens Boots Alliance | 55 |
Management Performance
Return On Equity | -26.29 | |||
Return On Asset | 8.0E-4 |
Rite Aid Leadership Team
Elected by the shareholders, the Rite Aid's board of directors comprises two types of representatives: Rite Aid inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Rite. The board's role is to monitor Rite Aid's management team and ensure that shareholders' interests are well served. Rite Aid's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Rite Aid's outside directors are responsible for providing unbiased perspectives on the board's policies.
Heyward Donigan, President, Chief Executive Officer, Director | ||
Elizabeth Burr, Independent Director | ||
Frank Vitrano, Chief Officer | ||
Douglas Donley, Chief Accounting Officer, Senior Vice President | ||
Michael Regan, Lead Independent Director | ||
Trent Kruse, Senior Vice President of Investor Relations, Treasury | ||
Jessica Kazmaier, Chief Human Resource Officer | ||
Lance Neill, Chief Operating Officer | ||
Brian Hoover, Chief Accounting Officer | ||
David Jessick, Independent Director | ||
Katherine Quinn, Independent Director | ||
Bruce Bodaken, Independent Chairman of the Board | ||
Matt Schroeder, Group Vice President Strategy, Investor Relations and Treasurer | ||
David Abelman, Executive Vice President - Marketing | ||
Frank Savage, Independent Director | ||
Marcy Syms, Independent Director | ||
James Comitale, Senior Vice President General Counsel, Secretary | ||
Byron Purcell, VP Treasurer | ||
Justin Mennen, Executive Vice President, Chief Information Officer | ||
Dedra Castle, Chief Human Resource Officer, Executive Vice President | ||
Erik Keptner, Senior Vice President Chief Marketing Officer | ||
Marc Strassler, Corporate Counsel | ||
Kenneth Martindale, Pres and CEO of Rite Aid Stores | ||
Derek Griffith, Executive Vice President - Store Operations | ||
Darren Karst, CFO, Chief Admin. Officer and Sr. Executive VP | ||
Jocelyn Konrad, Executive Vice President - Pharmacy and Retail Operations | ||
Matthew Schroeder, Chief Financial Officer, Executive Vice President | ||
Robert Knowling, Independent Director | ||
Doug Donley, Chief Accounting Officer, Senior Vice President | ||
Joseph Anderson, Independent Director | ||
Angele RobinsonGaylord, Senior Vice President - Store Development | ||
Jim Peters, Chief Operating Officer | ||
Bari Harlam, Independent Director | ||
Christopher Hall, VP Services | ||
Arun Nayar, Independent Director | ||
Paul Gilbert, Executive Vice President, General Counsel, Company Secretary | ||
Myrtle Potter, Director | ||
Kevin Lofton, Independent Director | ||
Kermit Crawford, President COO | ||
Chris Bohrer, Senior Vice President - Payor and Strategic Initiatives | ||
Steve Rempel, Senior Vice President CIO | ||
Roxanne Schwans, Senior Vice President - Market Access and Pharmacy Purchasing | ||
Enio Montini, Executive Vice President - Merchandising | ||
Louis Miramontes, Independent Director | ||
Joy Seusing, VP Officer | ||
Heyward BA, CEO Pres | ||
Andre Persaud, Executive Vice President - Retail | ||
Bryan Everett, Executive Vice President - Store Operations | ||
John Standley, Chairman, CEO and Chairman of Executive Committee | ||
James Peters, Chief Operating Officer |
Rite Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Rite Aid a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -26.29 | |||
Return On Asset | 8.0E-4 | |||
Profit Margin | (0.04) % | |||
Operating Margin | 0.0004 % | |||
Current Valuation | 6.08 B | |||
Shares Outstanding | 56.7 M | |||
Shares Owned By Insiders | 2.66 % | |||
Shares Owned By Institutions | 49.33 % | |||
Number Of Shares Shorted | 18.07 M | |||
Price To Earning | 0.86 X |
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Rite Aid information on this page should be used as a complementary analysis to other Rite Aid's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Rite Stock
If you are still planning to invest in Rite Aid check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Rite Aid's history and understand the potential risks before investing.
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |